MMUT

MMUT encodes methylmalonyl-CoA mutase, an adenosylcobalamin-dependent mitochondrial enzyme whose loss of function causes mut-type methylmalonic acidemia (MMA) (PMID:1670635, PMID:8990001). Disease alleles fall into two biochemical classes: mut(0) mutations that abolish enzyme activity, and mut(-) mutations that preserve residual cobalamin-dependent activity but raise the Km for adenosylcobalamin (PMID:8990001). The enzyme is organized into discrete functional domains, with mut(-) missense alleles almost exclusively clustering in the C-terminal adenosylcobalamin (cofactor) binding domain, establishing this domain as critical for cofactor binding, while mut(0) mutations are more broadly distributed (PMID:15643616, PMID:27167370). Interallelic complementation observed between certain mut(0) and mut(-) alleles indicates that the enzyme functions as a multimer in which distinct mutations impair separable components of apoenzyme function (PMID:1670635, PMID:8990001). Across the spectrum of mutation types, reduced steady-state protein is a common downstream consequence, marking protein instability as a major shared mechanism of deficiency (PMID:27167370). The position of cobalamin-binding-domain mutations also tracks with clinical responsiveness to vitamin B12, with specific genotypes conferring complete, partial, or absent normalization of metabolite levels (PMID:34668645).

1. 1990 Medium

   Established that MMUT deficiency in mut-type MMA is genetically heterogeneous and that defective mRNA expression, not only coding mutations, contributes to enzyme loss.

   Evidence Southern/Northern blot and propionate incorporation phenotyping across patient fibroblast lines

   PMID:1968706

   Open questions at the time

   • Did not define the specific lesions reducing mRNA
   • No correlation of mRNA defects with protein-level or catalytic consequences
2. 1991 High

   Demonstrated by gene transfer that a single missense allele behaves as mut(0) in one background yet supports apoenzyme function in complementing mut(-) backgrounds, providing direct evidence that distinct mutations hit separable functional components and that the enzyme acts as a multimer.

   Evidence MUT cDNA cloning/mutagenesis, gene transfer into patient fibroblasts, somatic cell complementation, propionate incorporation assay

   PMID:1670635

   Open questions at the time

   • Did not map the structural basis of the complementation
   • Multimeric stoichiometry not directly determined
3. 1997 Medium

   Defined the two biochemical phenotype classes mechanistically — mut(0) as complete loss and mut(-) as residual activity with elevated Km for adenosylcobalamin — linking mutation class to specific catalytic/cofactor-binding defects.

   Evidence Enzyme activity and Km determination, somatic cell complementation, molecular sequencing

   PMID:8990001

   Open questions at the time

   • Domain assignment not yet anchored to a structural model
   • Synthesis from existing alleles rather than systematic structure-function mapping
4. 2005 Medium

   Mapped novel missense mutations onto a homology model to show mut(-) alleles concentrate in the C-terminal adenosylcobalamin-binding domain while mut(0) alleles distribute broadly, locating the cofactor-binding function structurally.

   Evidence cDNA/gDNA sequencing of 40 patients, 3D homology modelling on P. shermanii MCM, biochemical phenotyping

   PMID:15643616

   Open questions at the time

   • Structural inference rests on homology, not a human crystal structure
   • Does not explain mechanism of broadly distributed mut(0) alleles
5. 2016 Medium

   Showed across 34 patient lines that MUT protein is reduced regardless of mut(0)/mut(-) class, identifying protein instability as a major shared mechanism of deficiency and reconfirming C-terminal localization of mut(-) missense alleles.

   Evidence Western blot of patient fibroblasts, propionate incorporation assay, MUT sequencing

   PMID:27167370

   Open questions at the time

   • Degradation pathway responsible for instability not identified
   • Single-lab cohort; protein turnover not measured directly
6. 2021 Low

   Correlated specific MMUT genotypes with complete, partial, or absent vitamin B12 responsiveness, extending mutation-class effects on cobalamin-dependent activity to clinical treatment response.

   Evidence Retrospective cohort of 266 patients with sequencing, acylcarnitine and organic acid profiling, B12 responsiveness testing

   PMID:34668645

   Open questions at the time

   • No in vitro enzymatic reconstitution to confirm cofactor-affinity mechanism
   • Responsiveness inferred from metabolite normalization, not direct kinetics
   • Genotype-phenotype association may be confounded by allele combinations

• The molecular basis of multimer assembly, the degradation pathway driving protein instability, and a direct human enzyme structure resolving cofactor-binding mechanism remain undefined in the available corpus.
• No human crystal structure in the corpus
• Multimer stoichiometry and assembly determinants unresolved
• Mechanism of mutation-induced protein turnover not established